SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma

SLC7A11 has significant translational value in cancer treatment. However, there are few studies on whether SLC7A11 affects the immune status of lung adenocarcinoma (LUAD). Information on SLC7A11 expression and its impact on prognosis was obtained from the cancer genome atlas and gene expression omni...

Descripción completa

Detalles Bibliográficos
Autores principales: Shan, Qingqing, Zhang, Chi, Li, Yangke, Li, Qunying, Zhang, Yifan, Li, Xue, Shi, Junqing, Hu, Fengying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600206/
https://www.ncbi.nlm.nih.gov/pubmed/37880315
http://dx.doi.org/10.1038/s41598-023-45284-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600206/
https://www.ncbi.nlm.nih.gov/pubmed/37880315
http://dx.doi.org/10.1038/s41598-023-45284-z

Ejemplares similares